Asimilar Group PLC - Exercise of Warrants, Issue of Equity & TVR
RNS Number : 6635G
Asimilar Group PLC
31 March 2022
 

The information contained in this announcement is deemed by the Company to constitute inside information as stipulated under the EU Market Abuse Regulation (596/2014). Upon publication of the announcement via a regulatory information service, this information is considered to be in the public domain.

31 March 2022

 

 

ASIMILAR GROUP PLC ('ASIMILAR' OR 'THE COMPANY')

 

Exercise of 333,333 Warrants, Issue of Equity and Total Voting Rights

 

Asimilar Group plc (AIM: ASLR), the AIM quoted investment company focused on technology opportunities in the fields of big data, machine learning, telematics and the Internet of Things (IoT), hereby announces that the Company has received a subscription notice exercising warrants to subscribe for 333,333 new ordinary shares in the Company at a subscription price of 5 pence per share (the "New Shares").

 

166,666 New Shares are being subscribed for by Dewscope Limited, in which Mark Horrocks has a 49% interest, and the remaining 166,667 are being subscribed for by Mr Horrocks' mother, Mrs DJ Horrocks.  Following admission of the New Shares, Mr Horrocks interest in the Company, including the shares held by Mrs DJ Horrocks, will be 5,756,280 ordinary shares, representing 4.7% of the Company's enlarged issued share capital.

Application will be made for the admission of the 333,333 New Shares to trading on AIM and it is expected that dealings in the New Shares will commence on or around 5 April 2022.  On admission the New Shares will rank pari passu in all respects with the Company's existing ordinary shares.

Total Voting Rights

Following admission of the New Shares the total issued share capital of the Company will consist of 122,257,276 Ordinary Shares, each with voting rights. This number may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Mark Horrocks

2

Reason for the notification

a)

Position/status

Non-executive Director

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Asimilar Group Plc

b)

LEI

213800AYJZ2B8QNY7H15

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 0.01 pence per share par value 

 

GB00BFX2VL54

b)

Nature of the transaction

Exercise of warrants

c)

Price(s) and volume(s)

Price(s)

Volume(s)

5p

166,666




d)

Aggregated information

-

Aggregated volume

-

Price

 

As above

As above

e)

Date of the transaction

30 March 2022

f)

Place of the transaction

Outside a trading venue

 

-Ends-

Contacts

Asimilar Group plc


John Taylor, Non-Executive Chairman

via Buchanan



Cairn Financial Advisers LLP


Sandy Jamieson / Liam Murray

Tel: +44 20 7213 0880



Peterhouse Capital Limited


Duncan Vasey / Lucy Williams

Tel: + 44 20 7220 9797



Buchanan Communications Limited


Richard Oldworth / Chris Lane

Tel: +44 (0) 20 7466 5000

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCURUNRUSUOOAR ]]>